C4 Therapeutics, Inc. (CCCC) is trading -5% lower at $11.24 today. So far the Health Care sector has been having a mildly bullish day, and the share price of the company is lagging behind it's peers.


C4 Therapeutics, Inc. has been trading between a 52-week high of $51.21 and a 52-week low of $4.84. The stock has a market cap of $550 Million.

C4 Therapeutics is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer and other diseases. This targeted protein degradation approach offers advantages over traditional therapies, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity.

C4 Therapeutics''s Return On Capital Employed Insights
Benzinga 08-22-22

C4 Therapeutics PT Lowered to $13 at Stifel
Investing.com 08-04-22

Recap: C4 Therapeutics Q2 Earnings
Benzinga 08-04-22

C4 Therapeutics GAAP EPS of -$0.56 beats by $0.12, revenue of $13.84M beats by $5.33M
Seeking Alpha 08-04-22

C4 Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
GlobeNewswire 08-04-22